Past year: ▲ 65%(36.5c – 1.34 AUD)
Each one in plain English, with the numbers worked through for a shareholder.
12 Jan 2026registration revoked● NeutralMajor
ASX removed Renergen from the Official List at close of trading on 12 January 2026, following implementation of the scheme of arrangement under which ASP Isotopes acquired all scheme shares for the scheme consideration.
2 Jan 2026business combination● Neutral
Scheme consideration remains 0.09196 ASPI shares per Renergen share, with fractions paid in cash. The cash value uses the ASPI JSE VWAP of R95.14792 less 10%, or R85.63313; payments are due 6 January 2026 (South Africa) and 13 January (CDI holders).
31 Dec 2025listing compliance notice● Neutral
ASX suspended Renergen's CDIs from quotation on 31 December 2025, following the scheme implementation timetable under which ASP Isotopes acquires all scheme shares.
18 Dec 2025business combination● NeutralMajor
Takeover Panel compliance certificate received, so the scheme proceeds. Key dates: last day to trade 30 December 2025 on the ASX, implementation 6 January 2026, and listing terminated on the JSE, A2X and ASX on or about 12 January 2026.
18 Dec 2025business combination▲ GoodMajor
All conditions to the ASP Isotopes scheme are now fulfilled or waived, making it unconditional; implementation follows the Takeover Panel's compliance certificate. The companies also cite positive Virginia operations, with a production update due end of January 2026.
28 Nov 2025business combination● Neutral
IDC and DFC consents to the transfer of Renergen shares were obtained, fulfilling one offer condition. The deadline for remaining conditions was extended to 30 January 2026, and Renergen's repayment date for ASPI's loan was also extended to 30 January 2026.
31 Oct 2025half year report▼ Bad
Auditor BDO's review report on the six months to 31 August 2025 is unmodified but flags a going-concern material uncertainty. Regulatory and lender approvals and timely completion of the ASPI offer to 30 September 2026 are the cited uncertainties. Text supplied has no financial figures.
29 Oct 2025other▼ Bad
Updated trading statement: loss per share for the six months to 31 August 2025 is expected at R0.866-R0.957, up 89-109% from R0.4573. This narrows the earlier 'at least 20%' guidance; the causes are unchanged.
22 Sept 2025other▼ Bad
Initial trading statement: loss per share for the six months to 31 August 2025 is expected to rise at least 20% from R0.4573. Stated causes: once-off ASPI deal costs, higher depreciation after full Phase 1 commissioning, expensed costs previously capitalised, and higher interest.
22 Sept 2025joint venture update▲ GoodMajor
Renergen and Springbok Solar settled all legal disputes with a coexistence agreement. Both the Virginia Gas Project and the solar project can operate in the area, and Tetra4 keeps exclusive production rights outside the solar facility boundary. This resolves the earlier Section 53 dispute.
16 Sept 2025business combination● Neutral
ASPI extended the deadline for the remaining ASP Isotopes scheme offer conditions from 30 September to 28 November 2025, citing regulatory and third-party approvals outside either party's control. Both remain committed; new dates follow once conditions are met.
28 Aug 2025other● Neutral
Associates of CEO Marani and COO Mitchell each sold 250,000 shares on 27 August 2025 at about R15.57, roughly R3.9m each. They still hold 5.45% and 5.38% respectively. This follows the earlier pledge of 17.3m shares to SBSA.
18 Aug 2025other● Neutral
Tetra4 non-executive director Mitesh Pema sold 4,500 shares at R16.71 on 14 August 2025, about R75,195. Routine dealing disclosure.
14 Aug 2025business combination● Neutral
Renergen and ASPI say the scheme timetable is slightly behind: not all offer conditions were met by the planned 14 August 2025. They call the remaining conditions well advanced, still due by 30 September 2025 unless extended; new dates will follow.
8 Aug 2025business combination▲ GoodMajor
All scheme conditions are fulfilled or waived, so the standby offer cannot be triggered. Only outstanding offer conditions remain, due by 30 September 2025. Share appreciation rights holders will get R0.08 cash per right, the expert's fair value being R0.09.
24 July 2025business combination▲ GoodMajor
The Competition Commission approved the ASPI offer on conditions acceptable to ASPI, satisfying one offer condition after shareholders passed the scheme resolutions on 10 July. Other conditions must still be met by 30 September 2025 unless extended.
10 July 2025joint venture update▼ BadMajor
Mahlako Gas Energy gave notice it is exercising its put option, which would force Renergen to repurchase its 5.5% Tetra4 stake (bought for R550m in 2023), at a price yet to be set. Renergen disputes the option event occurred and will challenge it.
27 June 2025annual report● Neutral
Integrated Annual Report 2025 combining the ESG report, remuneration report and audited financial statements for the year to 28 February 2025. Text supplied is only the contents and introduction, so no new figures are stated; repeats earlier results.
27 June 2025other● Neutral
Directors Marani, Mitchell and Harvey exercised Bonus Share Plan options at R0 strike after vesting on 20 June 2025, then sold some shares for tax. Net director acquisitions were 37,521, 38,664 and 22,073 shares. Routine dealing disclosure.
19 June 2025contract award▲ GoodMajor
The He4u consortium (Chart Industries, WBHO-Ovcon, Aurex) was named preferred bidder for the Phase 2 EPC contract. This satisfies one of the two remaining conditions for the DFC Phase 2 loan, moving Phase 2 closer to construction.
13 June 2025business combination● NeutralMajor
Circular and notice of a 10 July 2025 general meeting were distributed for the ASP Isotopes scheme (0.09196 ASPI shares per Renergen share). If the scheme becomes operative, Renergen delists from the JSE, A2X and ASX; a standby offer applies if the scheme fails.
13 June 2025business combination● Neutral
Combined circular sets out the ASPI scheme: 0.09196 new ASPI shares per Renergen share, with cash only for fractions, and delisting from JSE, A2X and ASX. It includes an independent expert report, a standby offer fallback and a vote on 10 July 2025. Repeats the known deal terms.
26 May 2025regulatory community update▲ GoodMajor
The Minister dismissed Springbok Solar's appeal, confirming helium falls within Tetra4's Production Right. This resolves the helium-rights challenge. Urgent relief against Springbok's construction failed on 23 May; the matter goes to the ordinary roll, likely heard in early June.
22 May 2025annual report● Neutral
Full FY25 consolidated and separate financial statements filed. Directors state the group will continue as a going concern, dependent on raising funding to complete Phase 1C. Repeats the audited results already released.
21 May 2025investor presentation● Neutral
Letter to shareholders announcing a webinar on the ASP Isotopes takeover, with CEO comments on its rationale, including access to US investors. Repeats the firm intention announcement; no new terms.
21 May 2025business combination▲ GoodMajor
Renergen and Nasdaq-listed ASP Isotopes agreed an all-share takeover by scheme of arrangement, with a standby general offer as fallback. Holders get 0.09196 ASPI shares per Renergen share; ASX CDI holders receive Nasdaq-listed shares. This replaces the planned Nasdaq IPO as the route to Phase 2 funding (inference).
19 May 2025annual report▼ Bad
Audited FY25 results confirm revenue R52.1m and loss of 159.10 cents per share. BDO's unmodified opinion again carries a going-concern material uncertainty tied to regulatory approvals and completing the funding initiatives.
7 May 2025regulatory community update▲ GoodMajor
On 2 May 2025 the High Court ruled the Gas Act does not apply to Tetra4's upstream production, on-site liquefaction or trading outside the piped gas industry, so no NERSA licence is needed. Helium is outside NERSA's reach. This resolves a case begun around December 2021.
30 Apr 2025annual report▼ Bad
Unaudited FY25 results: revenue R52.1m (up 79.7%), loss R236.1m (159.10 cents per share versus 75.10). LNG sales were 4,633 tonnes. Net tangible assets fell to R7.03 per share. Higher costs followed plant commissioning; audit still in progress.
28 Apr 2025other▼ Bad
JSE trading statement: loss per share for the year to 28 Feb 2025 expected at R1.52-R1.67, versus R0.751 the prior year. Figures are unaudited.
